Dysregulation of ribosome biogenesis and translational capacity is associated with tumor progression of human breast cancer cells
Stéphane Belin, Anne Beghin, Eduardo Solano-Gonzàlez, Laurent Bezin, Stéphanie Brunet-Manquat, Julien Textoris, Anne-Catherine Prats, Hichem C Mertani, Charles Dumontet, Jean-Jacques Diaz, Stéphane Belin, Anne Beghin, Eduardo Solano-Gonzàlez, Laurent Bezin, Stéphanie Brunet-Manquat, Julien Textoris, Anne-Catherine Prats, Hichem C Mertani, Charles Dumontet, Jean-Jacques Diaz
Abstract
Protein synthesis is a fundamental cell process and ribosomes - particularly through the ribosomal RNA that display ribozyme activity--are the main effectors of this process. Ribosome biogenesis is a very complex process involving transcriptional aswell as many post-transcriptional steps to produce functional ribosomes. It is now well demonstrated that ribosome production is enhanced in cancer cells and that ribosome biogenesis plays a crucial role in tumor progression. However, at present there is an important lack of data to determine whether the entire process of ribosome biogenesis and ribosome assembly is modified during tumor progression and what could be the potential impact on the dysregulation of translational control that is observed in cancer cells. In breast cancer cells displaying enhanced aggressivity, both in vitro and in vivo, we have analyzed the major steps of ribosome biogenesis and the translational capacity of the resulting ribosome. We show that increased tumorigenicity was associated with modifications of nucleolar morphology and profound quantitative and qualitative alterations in ribosomal biogenesis and function. Specifically cells with enhanced tumor aggressivity displayed increased synthesis of 45S pre-rRNA, with activation of an alternative preRNA synthetic pathway containing a 43S precursor and enhanced post-transcriptional methylation of specifc sites located in the 28S rRNA. While the global translational activity was not modified, IRES-initiated translation, notably that of p53 mRNA, was less efficient and the control of translational fidelity was importantly reduced in cells with increased aggressivity. These results suggest that acquisition of enhanced tumor aggressivity can be associated with profound qualitative alterations in ribosomal control, leading to reduced quality control of translation in cancer cells.
Conflict of interest statement
Competing Interests: The authors have declared that no competing interests exist.
Figures
References
- Boisvert FM, van Koningsbruggen S, Navascues J, Lamond AI. The multifunctional nucleolus. Nat Rev Mol Cell Biol 2007
- Coute Y, Burgess JA, Diaz JJ, Chichester C, Lisacek F, et al. Deciphering the human nucleolar proteome. Mass Spectrom Rev. 2006;25:215–234.
- Scherl A, Coute Y, Deon C, Calle A, Kindbeiter K, et al. Functional proteomic analysis of human nucleolus. Mol Biol Cell. 2002;13:4100–4109.
- Derenzini M. The AgNORs. Micron. 2000;31:117–120.
- Pich A, Chiusa L, Margaria E. Prognostic relevance of AgNORs in tumor pathology. Micron. 2000;31:133–141.
- Ofner D. In situ standardised AgNOR analysis: a simplified method for routine use to determine prognosis and chemotherapy efficiency in colorectal adenocarcinoma. Micron. 2000;31:161–164.
- Melese T, Xue Z. The nucleolus: an organelle formed by the act of building a ribosome. Curr Opin Cell Biol. 1995;7:319–324.
- Fromont-Racine M, Senger B, Saveanu C, Fasiolo F. Ribosome assembly in eukaryotes. Gene. 2003;313:17–42.
- Hadjiolova KV, Nicoloso M, Mazan S, Hadjiolov AA, Bachellerie JP. Alternative pre-rRNA processing pathways in human cells and their alteration by cycloheximide inhibition of protein synthesis. Eur J Biochem. 1993;212:211–215.
- Rouquette J, Choesmel V, Gleizes PE. Nuclear export and cytoplasmic processing of precursors to the 40S ribosomal subunits in mammalian cells. Embo J. 2005;24:2862–2872.
- Lestrade L, Weber MJ. snoRNA-LBME-db, a comprehensive database of human H/ACA and C/D box snoRNAs. Nucleic Acids Res. 2006;34:D158–162.
- Maden BE. Mapping 2′-O-methyl groups in ribosomal RNA. Methods. 2001;25:374–382.
- Reichow SL, Hamma T, Ferre-D'Amare AR, Varani G. The structure and function of small nucleolar ribonucleoproteins. Nucleic Acids Res. 2007;35:1452–1464.
- Baxter-Roshek JL, Petrov AN, Dinman JD. Optimization of Ribosome Structure and Function by rRNA Base Modification. PLoS ONE. 2007;2:e174.
- Chaudhuri S, Vyas K, Kapasi P, Komar AA, Dinman JD, et al. Human ribosomal protein L13a is dispensable for canonical ribosome function but indispensable for efficient rRNA methylation. Rna. 2007;13:2224–2237.
- Liu B, Liang XH, Piekna-Przybylska D, Liu Q, Fournier MJ. Mis-targeted methylation in rRNA can severely impair ribosome synthesis and activity. RNA Biol. 2008;5
- Ruggero D, Grisendi S, Piazza F, Rego E, Mari F, et al. Dyskeratosis congenita and cancer in mice deficient in ribosomal RNA modification. Science. 2003;299:259–262.
- Ruggero D, Pandolfi PP. Does the ribosome translate cancer? Nat Rev Cancer. 2003;3:179–192.
- Yoon A, Peng G, Brandenburger Y, Zollo O, Xu W, et al. Impaired control of IRES-mediated translation in X-linked dyskeratosis congenita. Science. 2006;312:902–906.
- Hahn WC, Counter CM, Lundberg AS, Beijersbergen RL, Brooks MW, et al. Creation of human tumour cells with defined genetic elements. Nature. 1999;400:464–468.
- Arabi A, Wu S, Ridderstrale K, Bierhoff H, Shiue C, et al. c-Myc associates with ribosomal DNA and activates RNA polymerase I transcription. Nat Cell Biol. 2005;7:303–310.
- Grandori C, Gomez-Roman N, Felton-Edkins ZA, Ngouenet C, Galloway DA, et al. c-Myc binds to human ribosomal DNA and stimulates transcription of rRNA genes by RNA polymerase I. Nat Cell Biol. 2005;7:311–318.
- Oskarsson T, Trumpp A. The Myc trilogy: lord of RNA polymerases. Nat Cell Biol. 2005;7:215–217.
- Trere D, Ceccarelli C, Montanaro L, Tosti E, Derenzini M. Nucleolar size and activity are related to pRb and p53 status in human breast cancer. J Histochem Cytochem. 2004;52:1601–1607.
- Barna M, Pusic A, Zollo O, Costa M, Kondrashov N, et al. Suppression of Myc oncogenic activity by ribosomal protein haploinsufficiency. Nature. 2008;456:971–975.
- Beghin A, Matera EL, Brunet-Manquat S, Dumontet C. Expression of Arl2 is associated with p53 localization and chemosensitivity in a breast cancer cell line. Cell Cycle. 2008;7:3074–3082.
- Beghin A, Honore S, Messana C, Matera EL, Aim J, et al. ADP ribosylation factor like 2 (Arl2) protein influences microtubule dynamics in breast cancer cells. Exp Cell Res. 2007;313:473–485.
- Decatur WA, Fournier MJ. rRNA modifications and ribosome function. Trends Biochem Sci. 2002;27:344–351.
- Sanchez PE, Fares RP, Risso JJ, Bonnet C, Bouvard S, et al. Optimal neuroprotection by erythropoietin requires elevated expression of its receptor in neurons. Proc Natl Acad Sci U S A. 2009;106:9848–9853.
- Navarro FP, Fares RP, Sanchez PE, Nadam J, Georges B, et al. Brain heparanase expression is up-regulated during postnatal development and hypoxia-induced neovascularization in adult rats. J Neurochem. 2008;105:34–45.
- White RJ. RNA polymerases I and III, growth control and cancer. Nat Rev Mol Cell Biol. 2005;6:69–78.
- Derenzini M, Trere D, Pession A, Montanaro L, Sirri V, et al. Nucleolar function and size in cancer cells. Am J Pathol. 1998;152:1291–1297.
- Liang XH, Liu Q, Fournier MJ. rRNA modifications in an intersubunit bridge of the ribosome strongly affect both ribosome biogenesis and activity. Mol Cell. 2007;28:965–977.
- Stoneley M, Paulin FE, Le Quesne JP, Chappell SA, Willis AE. C-Myc 5′ untranslated region contains an internal ribosome entry segment. Oncogene. 1998;16:423–428.
- Nanbru C, Lafon I, Audigier S, Gensac MC, Vagner S, et al. Alternative translation of the proto-oncogene c-myc by an internal ribosome entry site. J Biol Chem. 1997;272:32061–32066.
- Wang SI, Mukhtar H. A high-efficiency translational control element with potential for cancer gene therapy. Int J Oncol. 2002;20:1269–1274.
- Cornelis S, Bruynooghe Y, Denecker G, Van Huffel S, Tinton S, et al. Identification and characterization of a novel cell cycle-regulated internal ribosome entry site. Mol Cell. 2000;5:597–605.
- Tinton SA, Schepens B, Bruynooghe Y, Beyaert R, Cornelis S. Regulation of the cell-cycle-dependent internal ribosome entry site of the PITSLRE protein kinase: roles of Unr (upstream of N-ras) protein and phosphorylated translation initiation factor eIF-2alpha. Biochem J. 2005;385:155–163.
- Ray PS, Grover R, Das S. Two internal ribosome entry sites mediate the translation of p53 isoforms. EMBO Rep. 2006;7:404–410.
- Giraud S, Greco A, Brink M, Diaz JJ, Delafontaine P. Translation initiation of the insulin-like growth factor I receptor mRNA is mediated by an internal ribosome entry site. J Biol Chem. 2001;276:5668–5675.
- Martineau Y, Le Bec C, Monbrun L, Allo V, Chiu IM, et al. Internal ribosome entry site structural motifs conserved among mammalian fibroblast growth factor 1 alternatively spliced mRNAs. Mol Cell Biol. 2004;24:7622–7635.
- Simonin D, Diaz JJ, Masse T, Madjar JJ. Persistence of ribosomal protein synthesis after infection of HeLa cells by herpes simplex virus type 1. J Gen Virol. 1997;78 (Pt 2):435–443.
- Greco A, Laurent AM, Madjar JJ. Repression of beta-actin synthesis and persistence of ribosomal protein synthesis after infection of HeLa cells by herpes simplex virus type 1 infection are under translational control. Mol Gen Genet. 1997;256:320–327.
- Madjar JJ, Arpin M, Buisson M, Reboud JP. Spot position of rat liver ribosomal proteins by four different two-dimensional electrophoreses in polyacrylamide gel. Mol Gen Genet. 1979;171:121–134.
- Madjar JJ, Arpin M, Marion MJ, Reboud JP. Comparison of the protein content of free and membrane-bound rat liver polysomes and of the derived subunits. Mol Biol Rep. 1977;3:289–296.
- Diaz JJ, Giraud S, Greco A. Alteration of ribosomal protein maps in herpes simplex virus type 1 infection. J Chromatogr B Analyt Technol Biomed Life Sci. 2002;771:237–249.
- Coute Y, Kindbeiter K, Belin S, Dieckmann R, Duret L, et al. ISG20L2, a novel vertebrate nucleolar exoribonuclease involved in Ribosome biogenesis. Mol Cell Proteomics 2007
Source: PubMed